These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 2684504)
1. Background and indications for Haemophilus influenzae type b vaccines consisting of capsular antigen coupled to protein carriers. Anderson PW; Stein EC; Insel RA Contrib Microbiol Immunol; 1989; 10():115-24. PubMed ID: 2684504 [No Abstract] [Full Text] [Related]
2. Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines. Madore DV; Phipps DC; Eby R; Johnson CL; Smith DH Contrib Microbiol Immunol; 1989; 10():125-50. PubMed ID: 2684505 [No Abstract] [Full Text] [Related]
3. Contemporary trends in conjugate vaccine development. Cruse JM; Lewis RE Contrib Microbiol Immunol; 1989; 10():1-10. PubMed ID: 2510970 [No Abstract] [Full Text] [Related]
4. Conjugated Haemophilus influenzae type b vaccine. Med Lett Drugs Ther; 1988 Apr; 30(764):47-8. PubMed ID: 3258400 [No Abstract] [Full Text] [Related]
5. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children. CMAJ; 1993 Jan; 148(2):199-214. PubMed ID: 8452591 [No Abstract] [Full Text] [Related]
6. Prevention of Haemophilus influenzae type b disease: vaccines and passive prophylaxis. Wenger JD; Ward JI; Broome CV Curr Clin Top Infect Dis; 1989; 10():306-39. PubMed ID: 2679698 [No Abstract] [Full Text] [Related]
7. Vaccines for Haemophilus influenzae type b as models for an otitis vaccine. Mäkelä PH; Käyhty H; Peltola H; Eskola J Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S73-5. PubMed ID: 2648298 [No Abstract] [Full Text] [Related]
8. Immunologic considerations for the development of conjugate vaccines. Garner CV; Pier GB Contrib Microbiol Immunol; 1989; 10():11-7. PubMed ID: 2510971 [No Abstract] [Full Text] [Related]
9. [Conjugated vaccines against Haemophilus influenzae type b]. Rümke HC; Poolman JT Ned Tijdschr Geneeskd; 1991 Jan; 135(1):4-7. PubMed ID: 2012643 [No Abstract] [Full Text] [Related]
10. High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines. Käyhty H; Eskola J; Peltola H; Saarinen L; Mäkelä PH J Infect Dis; 1992 Jun; 165 Suppl 1():S165-6. PubMed ID: 1588156 [No Abstract] [Full Text] [Related]
11. Haemophilus influenzae type b vaccine. Anderson P; Pichichero ME Pediatrics; 1989 Jan; 83(1):145-6. PubMed ID: 2909967 [No Abstract] [Full Text] [Related]
12. Effect of oligosaccharide chain length, exposed terminal group, and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen unterminally coupled to the diphtheria protein CRM197. Anderson PW; Pichichero ME; Stein EC; Porcelli S; Betts RF; Connuck DM; Korones D; Insel RA; Zahradnik JM; Eby R J Immunol; 1989 Apr; 142(7):2464-8. PubMed ID: 2784464 [TBL] [Abstract][Full Text] [Related]
14. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development. Jennings HJ Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499 [No Abstract] [Full Text] [Related]
15. Responses of children to booster immunization with their primary conjugate Haemophilus influenzae type B vaccine or with polyribosylribitol phosphate conjugated with diphtheria toxoid. Decker MD; Edwards KM; Bradley R; Palmer P J Pediatr; 1993 Mar; 122(3):410-3. PubMed ID: 8441096 [TBL] [Abstract][Full Text] [Related]
16. [Prospects for the vaccinal prevention of Haemophilus influenzae type b meningitis]. Armand J Pathol Biol (Paris); 1983 Feb; 31(2):144-8. PubMed ID: 6341945 [TBL] [Abstract][Full Text] [Related]